Unknown NA INTERVENTIONAL 1-arm NCT03166059

CaveoVasc Thrombolysis Protection System, Access Protection Study

Prospective, Single Arm, Study to Assess the Safety and Performance of the CaveoVasc® Thrombolysis Protection System, for Femoral Artery Access and Protection in Patients Treated With Thrombolysis for Limb Ischemia

Sponsor: CaveoMed GmbH

Conditions Thrombolysis

Interventions CaveoVasc® Thrombolysis Protection System

Updated 6 times since 2017 Last updated: Dec 21, 2017 Started: Jan 31, 2018 Primary completion: Jan 31, 2018 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Thrombolysis and is currently ongoing. CaveoMed GmbH leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jun 2019 [monthly]

Not Yet Recruiting NA

▶ Show 1 earlier version

Jun 2017 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CaveoMed GmbH
MedPass International

Data source: CaveoMed GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.